Home Health Costs Topics

Health Costs

The MIDTERMS

“...the search for a single top issue through polling questions — whether it’s health costs, or gas prices, or the cost of food — is artificial. People worry about and experience these costs together. There is no top issue, unless that issue is the catchall, ‘cost of living.’” — Drew Altman, KFF Founding President and CEO

Are Health Care Costs THE Top Issue for Voters?

In a new column, Dr. Drew Altman, Founding President and CEO, analyzes the polling on health costs as a voting issue and concludes that there is no one top voting issue. He writes: “I have come to the conclusion that the search for a single top issue through polling questions—whether it’s health costs, or gas prices, or the cost of food—is artificial. People worry about and experience these costs together. There is no top issue, unless that issue is the catchall, “cost of living.”

Health System Tracker

Small Businesses Could See Double-Digit Premium Increases in 2027, According to Insurers’ Preliminary Rate Filings

Nearly 300 insurers offering offering health coverage to small businesses reported a median proposed premium increase of 14% for next year, according to an analysis of preliminary rate filings from all 50 states and DC.

ACA Marketplace Insurers Are Proposing a Median Premium Increase of About 15% in 2027

ACA Marketplaces insurers are proposing a median premium increase of 15% in 2027, according to an updated analysis of 276 insurers with publicly available filings across all 50 states and the District of Columbia.

In 2024, life expectancy in the U.S. reached an all-time high of 79 years but remained years behind the average in comparable countries

Life expectancy at birth in the U.S. increased 0.6 years from 78.4 years in 2023 to 79.0 years in 2024, its highest-ever level. However, the average life expectancy in comparable countries was about 3.7 years longer than in the U.S.

Among adults 18 - 64 with private insurance, mental health and substance use treatment accounted for 10% of all overnight stays at hospitals or other medical facilities in 2023.

Using claims data from the 2023 Merative MarketScan Commercial Claims Database, this analysis describes the most common diagnoses for inpatient treatment and total associated costs, including patients’ out-of-pocket share.

New and noteworthy

How Unaffordable is Health Care and What Can We Do About It?

Event Date:

On Tuesday, July 21, three experts joined Health Wonk Shop series moderator Larry Levitt in an hour-long discussion of health care affordability. During the discussion, panelists considered affordability from a variety of perspectives, including how to define affordability and the question of affordability for whom, how to measure it, and what can be done to address affordability and the underlying cost of health care.

Latest News

More KFF Health News

Stay informed.

Get KFF's latest on Health Costs

Stay informed.

Get KFF's latest on Health Costs

View the Latest: Health Costs

Filter

List Grid

891 - 900 of 1,603 Results

  • ACA’s Maximum Out-of-Pocket Limit Is Growing Faster Than Wages

    Issue Brief

    This analysis finds that the ACA’s maximum out-of-pocket limit is likely to grow faster than wages and salaries, and is also expected to grow faster than the maximum out-of-pocket limit for Health Savings Account (HSA)-qualified health plans.

  • Five Things to Know about the Renewal of Extra Affordable Care Act Subsidies in the Inflation Reduction Act

    Policy Watch

    As part of the Inflation Reduction Act, the Senate recently passed a three-year extension (through 2025) of enhanced subsidies for people buying their own health coverage on the Affordable Care Act Marketplaces. The enhanced subsidies increase the amount of financial help available to those already eligible and also newly expand subsidies to middle-income people, many of whom were previously priced out of coverage. Here’s what to know about the likely renewal of these subsidies:

  • The Biggest Health Care Reform in a Decade Could Lower Your Costs

    Perspective

    Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act  in The New York Times guest essay, “The Biggest Health Care Reform in a Decade Could Lower Your Costs.” 

  • 4 in 10 Workers – and 6 in 10 of Those with Low Incomes – Say They Missed Work During the Omicron Surge Due to COVID-19 Illness, Quarantine or Closure

    News Release

    The surge in COVID-19 cases triggered by the omicron variant led to widespread work disruptions, with about 4 in 10 workers (42%) – including 6 in 10 of those with lower incomes – saying they had to miss work at least once in the past three months because of a COVID-19 illness, quarantine, or closure, a new KFF COVID-19 Vaccine Monitor report shows. Among all workers, a quarter (26%) say they missed work because they…

  • Summary of Costs and Impact of the Prescription Drug Provisions in the Build Back Better Act

    News Release

    As the House-passed Build Back Better Act moves to the Senate, a new explainer from KFF summarizes the key prescription drug provisions within the broader budget reconciliation bill. These provisions would lower prescription drug costs paid by people with Medicare and private insurance and curb drug spending by the federal government and private payers. The Congressional Budget Office estimates federal budget savings from the drug pricing provisions would be $297 billion over 10 years. Although…

  • Updated Health Spending Explorer Features the Latest National Data

    News Release

    New 2020 data on U.S. health spending are now available on the Health Spending Explorer, an interactive tool that allows users to explore trends in health expenditures by federal and local governments, insurers, service providers, and individuals. The data, which span from 1960 to 2020, are based on the just-released national health spending report from the federal government. The new data reflect the country experiencing a global pandemic which impacted health care spending and policymaking…

  • Why Medicare’s Aduhelm Coverage Decision Could Increase Pressure on Officials to Roll Back the Record Part B Premium Increase for 2022

    News Release

    In a new Policy Watch, KFF experts explain why Medicare’s preliminary decision to cover a new Alzheimer’s drug only for a limited group of beneficiaries is likely to intensify pressure on officials to reconsider the increase in the Medicare Part B premium for 2022. Earlier this week, CMS issued a preliminary National Coverage Determination that would limit coverage of the new drug, Aduhelm, to beneficiaries with mild cognitive impairment who participate in approved clinical trials…

  • How Are Private Insurers Covering At-Home Rapid COVID Tests?

    Policy Watch

    This policy watch provides an early look at how top private insurers are implementing a new requirement to cover the cost of at-home COVID-19 tests. Initially about half offer a direct coverage option and half require an enrollee to pay upfront and then seek reimbursement.